# A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection

> **NCT06615921** · — · COMPLETED · sponsor: **Takeda** · enrollment: 265 (actual)

## Conditions studied

- Cytomegalovirus (CMV)

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT06615921
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-14
- **Primary completion:** 2025-07-04
- **Final completion:** 2025-07-04
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06615921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06615921, "A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06615921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*